Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
160.6 EUR | -1.07% | +2.32% | -9.42% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- With an expected P/E ratio at 32.48 and 29.28 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.42% | 80.23B | - | ||
+24.38% | 3.68B | B- | ||
+3.62% | 3.27B | B- | ||
+12.67% | 1.67B | - | ||
-2.54% | 1.28B | - | ||
-26.28% | 1.22B | B | ||
-30.27% | 1.19B | C- | ||
-21.20% | 1.05B | - | ||
-11.84% | 943M | - | ||
-1.49% | 915M | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ZTS Stock
- ZOE Stock
- Ratings Zoetis Inc.